Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A First-in-Human Phase 1/2 Study of ABCL635 in Healthy Participants and in Postmenopausal Women With Moderate-to-Severe Vasomotor Symptoms

NCT07118891 is registered in ClinicalTrials.gov with AbCellera Biologics Inc. as lead sponsor.

NCT NCT07118891
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07118891 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A First-in-Human Phase 1/2 Study of ABCL635 in Healthy Participants and in Postmenopausal Women With Moderate-to-Severe Vasomotor Symptoms
Lead sponsor
AbCellera Biologics Inc.
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
June 23, 2025
Completion date
February 28, 2027
Enrollment
136 (estimated)
Sites
13

Conditions

As the registry lists them; a condition with its own page is linked.

healthy volunteers, vasomotor symptoms associated with menopause